Actively Recruiting
The Adjunctive Effect of a Titanium Brush in the Non-Surgical Treatment of Peri-Implantitis
Led by Universitat Internacional de Catalunya · Updated on 2025-02-25
36
Participants Needed
1
Research Sites
109 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Peri-implantitis is a plaque-associated condition occurring around dental implants, characterized by inflammation in the peri-implant mucosa and loss of supporting bone. To stop this progression, mechanical debridement of biofilm and calculus is commonly used to treat peri-implant lesions as well as the use of adjunctive measures such as titanium brushes. As observed, they improved plaque removal when compared with steel curettes alone. Therefore, it is of interest to evaluate the impact of this procedure in terms of clinical, radiographic and microbiological outcomes to assess their efficacy.
CONDITIONS
Official Title
The Adjunctive Effect of a Titanium Brush in the Non-Surgical Treatment of Peri-Implantitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Ability to understand and comply with all study procedures and provide written informed consent
- Adequate oral hygiene with plaque index 25% or less
- Previously treated periodontal disease
- At least one titanium implant with peri-implantitis characterized by bleeding and/or suppuration on gentle probing, probing depth of 6 mm or more, and progressive bone loss
- Presence of horizontal and vertical peri-implant bone defects
- Implant in function for at least 1 year
- At least 2 mm of keratinized peri-implant mucosa present
- Screw-retained single or multiple restorations present
You will not qualify if you...
- Untreated periodontitis
- Smoking more than 10 cigarettes per day
- Local or systemic diseases interfering with periodontal therapy, including uncontrolled diabetes, cancer, HIV, chronic high-dose steroid therapy, metabolic bone disease, radiation exposure, immunosuppressive or autoimmune diseases, hepatic dysfunction
- Pregnant or lactating women
- Surgical or non-surgical treatment of affected implants within 12 months before study start
- Radiographic peri-implant bone loss greater than two-thirds of the implant
- Mobility of the implant
- Known allergy or intolerance to macrolides
- Use of systemic antibiotics in the last 3 months
- Need for endocarditis prophylaxis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitat Internacional de Catalunya
Barcelona, Catalonia, Spain, 08195
Actively Recruiting
Research Team
J
Javi Vilarrasa
CONTACT
F
Fares Al Hajeb
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here